Its lead product, PHER-02, is an intravenous perfluorocarbon
emulsion that is highly efficient at dissolving and delivering oxygen to tissues.
New Alliance PharmaceuticalsA is holder ofA an exclusive licence for perfluorocarbon
product Oxygent, whose extensive clinical history will earn Sanguine a leading position in oxygen therapy research and development, according to Sanguine's president, Frank Marra.
Department of Energy's National Energy Technology Laboratory used colorless, nontoxic liquids called perfluorocarbon
tracers to essentially fingerprint carbon dioxide that was injected into a coal seam in northwestern New Mexico.
The method involves the addition of perfluorocarbon
tracers (PFTs) to the injected C[O.
Durham, NC) has submitted a patent application for a new invention that uses Oxycyte perfluorocarbon
to deliver oxygen as a first aid treatment for victims of heart attacks and strokes.
has reached a development and commercial supply agreement with Hospira's One 2 One Global Pharmaceutical Services business unit to manufacture clinical-grade Oxycyte, a perfluorocarbon
(PFC) therapeutic oxygen carrier.
The topics of their seven papers include the interaction of drug transporters with excipients, formulation issues around lipid-based oral and parenteral delivery systems, the biological implications of lipid-based parenteral delivery systems, principles in the development of intravenous lipid emulsions, the key factor of protein absorption patterns in determining the in vivo fate of parenteral lipid formulations; nanoparticple targeting for drug delivery across the blood-brain barrier, and lipid-coated perfluorocarbon
structures as parenteral therapeutic agents.
The lower-than-anticipated emissions generated by the CFC substitutes -- hydrofluorocarbon, perfluorocarbon
and sulfur hexafluoride -- would help the country achieve its targets for cutting greenhouse-gas emissions under the 1997 Kyoto Protocol to combat global warming, the sources told Kyodo News.
However, you can now use most of these donors following preservation with a special system that includes an oxygenated perfluorocarbon
SYBD currently is developing three products: Oxycyte(TM), a perfluorocarbon
-based blood substitute and therapeutic oxygen carrier; Fluorovent(TM), a perfluorocarbon
liquid ventilation product; and an implantable glucose biosensor for continuous monitoring of blood glucose levels in diabetics.
The oxygen-rich liquid - perfluorocarbon
(PFC) - re-expands the lungs and gives them the oxygen the body needs.
The Company has developed a proprietary perfluorocarbon
(PFC) therapeutic oxygen carrier called Oxycyte[R] that is currently in clinical and preclinical studies for intravenous delivery for indications such as traumatic brain injury, decompression sickness and stroke.